Mantan Mukta, Singh Srijan
Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital, University of Delhi, New Delhi, India.
Saudi J Kidney Dis Transpl. 2019 Nov-Dec;30(6):1245-1253. doi: 10.4103/1319-2442.275468.
Children with nephrotic syndrome (NS) encounter multiple episodes of relapses associated/triggered by an episode of infection. The primary objective of this study was to find the proportion of infection associated relapses that resolve on the treatment of acute infection over an observation period of two weeks in children with NS. This prospective observational study enrolled 45 children with steroid-sensitive NS presenting with an infection associated relapse during the study period (February 2015 to February 2016). Baseline information and examination findings of all children were recorded. Biochemical and other investigations were performed according to the site of infection for all patients and were treated appropriately. None of the patients received daily 2 mg/kg of prednisolone during the observation period. All children were followed for two weeks for resolution of relapse and subsequently every month for another three months. The 45 patients (median age 66 months) enrolled in the study had 64 episodes of infections, of which upper respiratory tract infections (45%) were the commonest, followed by peritonitis (18.5%) and diarrhea in 12%. Twenty-seven (60%) patients achieved remission on symptomatic treatment of infection with/without the use of stress doses of prednisolone. Most (77.8%) patients who achieved remission without the use of daily 2 mg/kg of prednisolone did so within the 1 week and a majority of patients were still in remission at three months follow-up. We conclude that most infection associated relapses can be managed with treatment of underlying infection alone and use of stress doses of steroids for inducing remission without increasing the prednisolone doses to 2 mg/kg/d and thus reducing the cumulative steroid doses.
患有肾病综合征(NS)的儿童会因感染发作而多次复发。本研究的主要目的是在肾病综合征患儿的两周观察期内,找出经急性感染治疗后缓解的感染相关性复发的比例。这项前瞻性观察研究纳入了45名在研究期间(2015年2月至2016年2月)出现感染相关性复发的激素敏感型肾病综合征患儿。记录了所有患儿的基线信息和检查结果。根据所有患者的感染部位进行了生化及其他检查,并给予适当治疗。在观察期内,没有患者接受每日2mg/kg的泼尼松龙治疗。所有患儿随访两周以观察复发是否缓解,随后每月随访三个月。纳入研究的45例患者(中位年龄66个月)共发生64次感染,其中上呼吸道感染最为常见(45%),其次是腹膜炎(18.5%),腹泻占12%。27例(60%)患者在使用或未使用应激剂量泼尼松龙的情况下,经感染对症治疗后病情缓解。大多数(77.8%)未使用每日2mg/kg泼尼松龙而病情缓解的患者在1周内实现缓解,且大多数患者在三个月的随访时仍处于缓解状态。我们得出结论,大多数感染相关性复发仅通过治疗潜在感染以及使用应激剂量的类固醇诱导缓解即可得到控制,无需将泼尼松龙剂量增加至2mg/kg/d,从而减少类固醇的累积剂量。